Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca-Daiichi Sankyo Enhertu gets USFDA Breakthrough Therapy Designation in HER2-positive early breast cancer

Ruchika Sharma22 Dec 2025 1:30 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo has announced that Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD)...

Ethylene Glycol Detected in Almont-Kid Syrup, Telangana Drug Regulator Orders Immediate Freeze

Cough syrup turns fatal for toddler in Jharkhand

Ruchika Sharma22 Dec 2025 12:30 PM IST

Koderma: A cough syrup purchased from a private medical store allegedly turned deadly for a one-and-a-half-year-old girl in Jharkhand’s Koderma...

Granules Pharma earns USFDA tentative nod for Attention Deficit Hyperactivity Disorder drug

Ruchika Sharma22 Dec 2025 11:21 AM IST

Hyderabad: Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received tentative approval from the U.S. Food and Drug...

Bayer Finerenone approved in Japan for chronic heart failure

Ruchika Sharma22 Dec 2025 10:30 AM IST

Berlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a non-steroidal, selective...

Abbott gets USFDA clearance for Amplatzer Piccolo Delivery System for premature babies with heart hole

Ruchika Sharma21 Dec 2025 3:15 PM IST

Abbott Park: Abbott has announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo...

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

Novo Nordisk seeks USFDA approval for once weekly CagriSema for weight management

Ruchika Sharma21 Dec 2025 2:30 PM IST

Plainsboro: Novo Nordisk has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...

Corona Remedies Bhayla facility commences additional commercial production of medicines

Govt sets target to increase Jan Aushadhi Kendras to 25000 by March 2027

Ruchika Sharma21 Dec 2025 2:30 PM IST

New Delhi: With a view to augment the reach of Janaushadhi scheme to the citizens, Government has set a target of increasing the number of JAKs opened...

Sanofi efdoralprin alfa earns orphan designation in EU for alpha-1 antitrypsin deficiency related emphysema

Ruchika Sharma21 Dec 2025 12:30 PM IST

Paris: Sanofi has announced that the European Medicines Agency (EMA) has granted orphan designation to efdoralprin alfa (SAR447537, formerly known as...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

Astrazeneca Saphnelo approved in EU for subcutaneous self-administration for systemic lupus erythematosus adults

Ruchika Sharma21 Dec 2025 11:30 AM IST

Cambridge: AstraZeneca has announced that Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous...

Use weight reducing drugs judiciously: Dr Jitendra Singh

Ruchika Sharma20 Dec 2025 7:37 PM IST

New Delhi: Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh, has said that weight reducing or anti-obesity...

Indore: Illegal ayurvedic syrup factory sealed

Ruchika Sharma20 Dec 2025 5:38 PM IST

Indore: An illegal Ayurvedic syrup manufacturing factory with no laboratory to test product quality was sealed in Madhya Pradesh’s Indore...

Boehringer Ingelheim, CDR-Life enter into new agreement to develop autoimmune disease molecule

Boehringer Ingelheim earns USFDA approval for Jascayd tablets for progressive pulmonary fibrosis

Ruchika Sharma20 Dec 2025 4:48 PM IST

Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD (nerandomilast) tablets for the treatment of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok